Css LLC Atea Pharmaceuticals, Inc. Put Options Transaction History

Css LLC

  • $999 Million
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$3.0 - $3.79 $7,800 - $9,854
-2,600 Reduced 10.12%
23,100 $69,000
Q2 2023

Aug 14, 2023
BUY
$3.21 - $5.06 $82,497 - $130,041
25,700 New
25,700 $96,000
Q3 2021

Nov 15, 2021
BUY
$21.33 - $35.06 $108,782 - $178,806
5,100 Added 49.51%
15,400 $540,000
Q2 2021

Aug 16, 2021
BUY
$19.22 - $59.08 $197,966 - $608,524
10,300 New
10,300 $221,000

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $270M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email